There’s a lot to be optimistic about in the Services sector as 2 analysts just weighed in on Genpact Limited (NYSE:G) and Charles River Labs (NYSE:CRL) with bullish sentiments.
Genpact Limited (G)
SunTrust Robinson analyst Frank Atkins reiterated a Buy rating on Genpact Limited yesterday and set a price target of $37. The company’s shares closed yesterday at $30.15.
According to TipRanks.com, Atkins is a 4-star analyst with an average return of 12.7% and a 73.3% success rate. Atkins covers the Technology sector, focusing on stocks such as DXC Technology Company, Sykes Enterprises Inc, and Exlservice Holdings.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Genpact Limited with a $36.67 average price target, which is a 21.6% upside from current levels. In a report released yesterday, Cantor Fitzgerald also maintained a Buy rating on the stock with a $36 price target.
.
See today’s analyst top recommended stocks >>
Charles River Labs (CRL)
SunTrust Robinson analyst Sandy Draper reiterated a Buy rating on Charles River Labs yesterday and set a price target of $135. The company’s shares closed yesterday at $124.18.
According to TipRanks.com, Draper is a 5-star analyst with an average return of 20.5% and a 78.9% success rate. Draper covers the Services sector, focusing on stocks such as PRA Health Sciences, IQVIA Holdings Inc, and Syneos Health Inc.
Charles River Labs has an analyst consensus of Strong Buy, with a price target consensus of $135.80, a 9.4% upside from current levels. In a report released yesterday, Robert W. Baird also reiterated a Buy rating on the stock with a $133 price target.
.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
